R-Biopharm Buys Majority Stake in Trilogy, Expands U.S. Operations
R-Biopharm AG, a developer of test solutions for clinical diagnostics and food and feed safety, has announced that they have purchased a majority ownership position in Trilogy Analytical Laboratory, Inc., based in Washington, MO.

Founded in 1999, Trilogy is considered a premier commercial testing laboratory for the detection of mycotoxins and other contaminants for food and feed safety. The company offers a consumable product line that includes purification columns, chromatography standards and certified reference materials for use in the detection of mycotoxins.

R-Biopharm currently has 13 subsidiary companies and distributes its products in more than 120 countries. R-Biopharm, Inc., the U.S. subsidiary, will relocate and combine its facilities and operations with Trilogy, although the two companies will continue to operate independently.

Q Laboratories Earns ISO/IEC 17025 Accreditation
Cincinnati, OH-based testing laboratory Q Laboratories, Inc. has achieved ISO/IEC 17025 Accreditation from the American Association of Laboratory Accreditation for multiple microbiological and analytical chemistry methods. The scope of methods covered includes bacteriological and pathogen detection (AOAC, FDA and ISO methods) as well as nutritional values and metals analysis. To achieve ISO/IEC 17025 accreditation, a laboratory must demonstrate proficiency in their quality system, standard operating procedures and laboratory performance.

“Attaining this accreditation is another indication of the excellent staff we have at Q Laboratories. From our Quality Assurance Unit to our lab managers, analysts and support staff, this process has been a team effort and is a testament to the exceptional team we have here at our lab,” said David Goins, president. ♦

June/July 2010